Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 7/20 | 0.68 |
| ▸ | HTT | P42858 | 4/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.68 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.68 |
| ▸ | MEN1 | O00255 | 5/20 | 0.63 |
| ▸ | MITF | O75030 | 2/20 | 0.63 |
| ▸ | NPC1 | O15118 | 1/20 | 0.63 |
| ▸ | RAB9A | P51151 | 1/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.58 |
| ▸ | LMNA | P02545 | 5/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.58 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | POLB | P06746 | 2/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.58 |
| ▸ | PTPRC | P08575 | 1/20 | 0.56 |
| ▸ | NAT1 | P18440 | 5/20 | 0.55 |
| ▸ | HPGD | P15428 | 3/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2241087 | 0.88 | MAPT (0.76) | MAPTKMT2AHTTMAPK1NPSR1 | |
| SCHEMBL1815994 | 0.87 | MAPT (0.71) | MAPTKMT2AHTTMAPK1NPSR1 | |
| SCHEMBL16297045 | 0.85 | KMT2A (0.68) | MAPTKMT2AHTTMAPK1NPSR1 | |
| SCHEMBL17742954 | 0.80 | MAPT (0.55) | MAPTKMT2AHTTMAPK1NPSR1 | |
| SCHEMBL2246284 | 0.78 | MAPT (0.61) | MAPTKMT2AHTTMAPK1NPSR1 | |
| SCHEMBL4868219 | 0.78 | MAPT (1.00) | MAPTKMT2AHTTMAPK1NPSR1 | |
| SCHEMBL2242640 | 0.77 | ALDH1A1 (0.62) | MAPTKMT2AHTTMAPK1NPSR1 | |
| SCHEMBL2241314 | 0.77 | KMT2A (0.71) | MAPTKMT2AHTTMAPK1NPSR1 | |
| SCHEMBL9178476 | 0.76 | LMNA (0.73) | MAPTKMT2AHTTMAPK1MEN1 | |
| SCHEMBL19625586 | 0.75 | MAPT (0.50) | MAPTKMT2AHTTMAPK1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170334842-A1 | INHIBITORS OF THE MITF MOLECULAR PATHWAY | UNIVERSITY OF KANSAS | 2017-11-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170334842-A1 | INHIBITORS OF THE MITF MOLECULAR PATHWAY | MITF, TFEB, TYR | MAPT 4092/4885KMT2A 2146/4885HTT 1443/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.